Normative errors and Surgisphere - Peter Attia
Greetings -
On June 4th, the Lancet and the New England Journal of Medicine retracted two high-profile COVID-19 papers after critics challenged the data in those studies. The Lancet paper found COVID-19 patients treated with hydroxychloroquine and chloroquine were associated with more deaths and adverse effects, resulting in the World Health Organization halting its clinical trials that use hydroxychloroquine to treat COVID-19 patients. The NEJM study found that certain blood pressure drugs, including ACE inhibitors, were not associated with an increased risk of death among COVID-19 patients. Last month, the New York Times profiled Dr. Sapan Desai, founder of Surgisphere, the company that supplied the data for both retracted studies. Desai is a co-author on both the Lancet and NEJM papers. The Times story should be a case study on the importance of “normative errors” and why they cannot be brushed aside in medicine (or, frankly, anywhere else).....
Ancient history. Does not change the lack of support in randomized controlled trials.